Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Autoimmune and inflammatory conditions Patients with autoimmune conditions including lupus, rheumatoid arthritis, and Hashimoto thyroiditis have increasing access to GLP-1 therapy, and the anti-inflammatory mechanism provides specific rationale for this use
Product Name: 5-Amino-1MQ Classification: NNMT Inhibitor / Metabolic Research Compound Structural Description: Small molecule NNMT inhibitor (non-peptide), 5-amino-1-methylquinolinium CAS Number: 685079-15-6 Molecular Weight: 159.21 Da Purity: 99% (verified by HPLC and Mass Spectrometry) Physical Form: See product label for form details Intended Use: In-vitro research use only not for human consumption Related research compounds Comparable catalog records with published variants and certificate status
Underlying conditions: Digestive or absorption issues
94664 Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device
